We advised AstraZeneca, a global research-based biopharmaceutical company in relation to the company’s participation in a novel public-private partnership to improve lung cancer patient pathway in cooperation and thus contribute jointly to the implementation of the national cancer control plan. New approach National cancer control plan until year 2030 highlights the problem that cancer patients’ […]
We are advising Riigi Kinnisvara AS (RKAS), a real estate development and management company established for the efficient management of the real estate belonging to the Estonian state, on the purchase (public procurement) of electricity produced from renewable sources. Commitment to renewable energy As one of the largest electricity consumers in Estonia, RKAS is starting […]
In cooperation with patent bureau Käosaar, we advised and represented the Estonian political party Eesti 200 (meaning Estonia 200) in a landmark trademark dispute with non-profit organization Eesti Kultuur 200 and its leader Kärt Summatavet. Registration of word mark opposed Following the launch of the political party Eesti 200 back in 2018, Summatavet and Eesti […]
We assisted Synbase, an Estonian service provider for healthcare professionals, on tackling various data protection matters and launching its revolutionary web portal offering access to various evidence-based medicine databases. Supporting healthcare professionals Synbase saves healthcare professionals time by combining the latest knowledge in evidence-based medicine into a convenient, comprehensive service offered now both via an […]
We advised Triumf Research (Triumf Health), a company dedicated to the improvement of children’s mental health, on tackling licensing questions with local governments in Estonia. Focus on the mental health of children Triumf Health has developed an interactive game Triumfland Saga for children between the ages of 7 -14. Triumfland Saga is designed specifically for […]